Influenza Immunity Against Pandemic Respiratory Virus

NCT00138281 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: FluMist
BIOLOGICAL: Fluzone

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)